Loading...
ROCO
4747
Market cap66mUSD
Oct 08, Last price  
23.35TWD
1D
0.86%
1Q
-53.30%
Jan 2017
-28.94%
IPO
37.68%
Name

Johnson Chemical Pharmaceutical Works Co Ltd

Chart & performance

D1W1MN
ROCO:4747 chart
P/E
39.68
P/S
3.73
EPS
0.59
Div yield, %
7.49%
Shrs. gr., 5y
22.04%
Rev. gr., 5y
6.09%
Revenues
570m
-6.81%
425,339,000424,015,000411,491,000494,671,000606,711,000611,415,000569,772,000
Net income
54m
-36.40%
64,471,00063,561,00049,099,00064,851,00079,700,00084,123,00053,505,000
CFO
72m
+14.04%
71,518,00071,773,00052,347,00089,685,000136,950,00062,877,00071,707,000
Dividend
Jul 06, 20261.05 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Johnson Chemical Pharmaceutical Works Co., Ltd., established in 1959 and headquartered in New Taipei City, Taiwan, is a Taiwanese company that engages in the manufacturing, importing, and distribution of pharmaceutical raw materials, active ingredients, and finished drug products. The company's diverse product portfolio addresses a wide spectrum of health conditions, encompassing areas such as the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine systems, alongside offerings for vitamin supplementation, anti-inflammatory needs, cough and cold remedies, and pain relief. These medicinal products are available in various forms, including traditional solid oral dosages like capsules, tablets, powders, and granules, as well as specialized delivery systems such as nasal sprays.

Key people

Boxiong Huang
Chairman of the Board · since 2025
Yicong Qiu
Deputy General Manager-Business · since 2012
Yixiu Chen
Head of Finance and Accounting, Corporate Governance Officer · since 2023
Boxun Huang
Director · since 2007
Yahui Lan
Director · since 2025
Haoxi Su
General Manager, Director · since 2025
Xiaohui Su
Director · since 2025
Changrui Yang
Director · since 2025
Rongfu Yang
Director · since 2004
Dairong Zhong
Director · since 2025
Zongcheng Lai
Independent Director · since 2012
Jianfa Lan
Independent Director · since 2012
Zhiheng Li
Independent Director · since 2012
Weitai Li
Independent Director · since 2025
Shengchao Peng
Independent Director · since 2025
IPO date
Jan 08, 2010
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT